[1]
CHANDANA KAMILI et al. 2016. Evaluation of antiangiogenic potential of lubiprostone, a clc-2 channel agonist by chorioallantoic Membrane assay. (cam). International Journal of Pharma and Bio Sciences. 7, 4 (Dec. 2016), 299–307.